Publication

Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways

Downloadable Content

Persistent URL
Last modified
  • 02/25/2025
Type of Material
Authors
    Robert N. Taylor, Wake Forest UniversityMaureen A. Kane, University of MarylandNeil Sidell, Emory University
Language
  • English
Date
  • 2015-07-01
Publisher
  • Georg Thieme Verlag
Publication Version
Copyright Statement
  • © 2015 by Thieme Medical Publishers, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1526-8004
Volume
  • 33
Issue
  • 4
Start Page
  • 246
End Page
  • 256
Grant/Funding Information
  • This work was supported by Eunice Kennedy Shriver/ National Institute of Child Health grants U01HD66439 (N. S., R. N. T.), R01HD55379 (N. S.), U54HD55787 (R. N. T.), R01HD077260 (M. A. K.), the National Institute of Allergy and Infectious Diseases contract HHSN272202000046C (M. A. K.), and the University of Maryland School of Pharmacy Mass Spectrometry Center SOP1841-IQB2014 (M. A. K.).
Abstract
  • Endometriosis is a nonmalignant, but potentially metastatic, gynecological condition manifested by the extrauterine growth of inflammatory endometrial implants. Ten percent of reproductive-age women are affected and commonly suffer pelvic pain and/or infertility. The theories of endometriosis histogenesis remain controversial, but retrograde menstruation and metaplasia each infer mechanisms that explain the immune cell responses observed around the ectopic lesions. Recent findings from our laboratories and others suggest that retinoic acid metabolism and action are fundamentally flawed in endometriotic tissues and even generically in women with endometriosis. The focus of our ongoing research is to develop medical therapies as adjuvants or alternatives to the surgical excision of these lesions. On the basis of concepts put forward in this review, we predict that the pharmacological actions and anticipated low side-effect profiles of retinoid supplementation might provide a new treatment option for the long-term management of this chronic and debilitating gynecological disease.
Author Notes
  • Address for correspondence: Robert N. Taylor, MD, PhD, Department of Obstetrics and Gynecology, Wake Forest School of Medicine, 1 Medical Center Boulevard, Winston-Salem, NC 27157, rtaylor@wakehealth.edu.
Keywords
Research Categories
  • Health Sciences, Obstetrics and Gynecology
  • Health Sciences, Pathology
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items